An evidence-based approach to the use of drug-eluting stents in clinical practice.

The American heart hospital journal

Volumn 2, Issue 3, 2004, Pages 132-141

  Kuntz, Richard E ^a   Wang, John C ^a   Mauri, Laura ^a   Cohen, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG DELIVERY SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; MASS COMMUNICATION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW; RISK REDUCTION; STENT;

CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; DIFFUSION OF INNOVATION; DRUG DELIVERY SYSTEMS; EVIDENCE-BASED MEDICINE; HUMANS; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS; RISK REDUCTION BEHAVIOR; SIROLIMUS; STENTS;

EID: 19544385994     PISSN: 15419215     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1541-9215.2004.02660.x     Document Type: Review

References (34)